Overview

Postmenopausal Women,Treatment of Sleep Apnea and Co-morbidities

Status:
Completed
Trial end date:
2000-11-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to evaluate the degree and duration of medroxyprogesterone acetate effect as well as tolerability in postmenopausal women with nasal continuous positive airway pressure (CPAP) treated sleep apnea and to compare the effects with nasal CPAP.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Turku University Hospital
Treatments:
Medroxyprogesterone
Medroxyprogesterone Acetate